FDA approvals

Another medium molecule hits the market
agosto 8, 2019

Bremelanotide (commercialized as Vyleesi) has recently been approved by the FDA for the treatment of low sexual desire in women.

Leer más
Macrocycles
Review of the Month: Opportunities with Macrocycles
junio 26, 2019

The macrocycles provides access to new chemical space and opportunities in drug discovery that are otherwise difficult to reach with small molecules.

Leer más